The enSonix@home device is undergoing QC testing for efficacy,
overall performance and durability. Sign offs to start the
manufacturing are expected within 30 days.

3. The in the field joint marketing program with a pharmaceutical
company is scheduled to commence mid September, at which time the
name of the company will be in the public domain;

4. HealthSonix plans to apply for a listing on the AMEX before the
end of this calendar year; all the necessary documentation to be
filed with the regulators is being prepared towards that end.

5. Management has scheduled IR meetings in New York, starting
September 18th, right through the end of November to acquaint
institutions and retail brokerage houses with the HealthSonix
products and services;